Serological response to Japanese encephalitis vaccine in a group of school children in South Arcot district of Tamil Nadu.
A trial with Biken Japanese encephalitis (JE) vaccine made in Japan was carried out in South Arcot district of Tamil Nadu state, India. A total of 113 school children were included in the trial. The efficacy (as determined by serological response) and safety of the vaccine were evaluated. Side effects, though minor, were noted in 54.9 per cent of the children after each dose. The serum antibody titres were determined by mouse neutralization test, plaque reduction neutralization test and haemagglutination inhibition test. An antibody response to two-dose primary vaccination schedule was observed in 72.7 per cent, whereas 87.8 per cent of the vaccines responded positively after the booster dose administered one year after. Only about 20 per cent of the children had persisting antibodies one year after the primary vaccination. The results indicated a probable need of the third dose in the primary vaccination schedule.
National Institute of Virology, Pune.
C V
CV
Mohan Rao
A R
AR
Risbud
C N
CN
Dandawate
U B
UB
Umarani
V M
VM
Ayachit
F M
FM
Rodrigues
K M
KM
Pavri
D000293:Adolescent; D000914:Antibodies, Viral / Q000097:blood; D002648:Child; D002675:Child, Preschool; D004664:Encephalitis Virus, Japanese / Q000276:immunology*; D005260:Female; D006801:Humans; D007117:Immunization, Secondary; D007194:India; D008297:Male; D014611:Vaccination; D014765:Viral Vaccines / Q000009:adverse effects / Q000276:immunology*
D000914:Antibodies, Viral; D014765:Viral Vaccines